Moreover, recent studies have elucidated the immunomodulatory properties of GSK-3β in the context of cancer, most importantly in regulating negative immune checkpoint molecules but also in directly enhancing the activity of innate and adaptive immune cells as it will be described in later sections. Here, GSK3B is linked to cancer.